SE0101324D0 - New process - Google Patents

New process

Info

Publication number
SE0101324D0
SE0101324D0 SE0101324A SE0101324A SE0101324D0 SE 0101324 D0 SE0101324 D0 SE 0101324D0 SE 0101324 A SE0101324 A SE 0101324A SE 0101324 A SE0101324 A SE 0101324A SE 0101324 D0 SE0101324 D0 SE 0101324D0
Authority
SE
Sweden
Prior art keywords
sup
formula
compound
alcohol
new process
Prior art date
Application number
SE0101324A
Other languages
English (en)
Swedish (sv)
Inventor
Lal Lashkar Singh Cheema
David Cladingboel
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Priority to SE0101324A priority Critical patent/SE0101324D0/xx
Publication of SE0101324D0 publication Critical patent/SE0101324D0/xx
Priority to HK04103893.8A priority patent/HK1060886B/en
Priority to PT02718766T priority patent/PT1385850E/pt
Priority to AU2002249748A priority patent/AU2002249748B2/en
Priority to PCT/SE2002/000727 priority patent/WO2002083690A1/en
Priority to JP2002581445A priority patent/JP4248880B2/ja
Priority to IL15824902A priority patent/IL158249A0/xx
Priority to KR1020037013158A priority patent/KR100848613B1/ko
Priority to NZ528515A priority patent/NZ528515A/en
Priority to BR0208861-4A priority patent/BR0208861A/pt
Priority to US10/474,593 priority patent/US7169921B2/en
Priority to AT02718766T priority patent/ATE284405T1/de
Priority to MXPA03009211A priority patent/MXPA03009211A/es
Priority to CNB028115759A priority patent/CN1267435C/zh
Priority to EP02718766A priority patent/EP1385850B1/de
Priority to ES02718766T priority patent/ES2233809T3/es
Priority to CA002443475A priority patent/CA2443475A1/en
Priority to DE60202203T priority patent/DE60202203T2/de
Priority to SI200230074T priority patent/SI1385850T1/xx
Priority to ZA200307676A priority patent/ZA200307676B/en
Priority to IL158249A priority patent/IL158249A/en
Priority to NO20034526A priority patent/NO20034526L/no
Priority to US11/612,826 priority patent/US20070197519A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/08—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Steroid Compounds (AREA)
SE0101324A 2001-04-12 2001-04-12 New process SE0101324D0 (sv)

Priority Applications (23)

Application Number Priority Date Filing Date Title
SE0101324A SE0101324D0 (sv) 2001-04-12 2001-04-12 New process
SI200230074T SI1385850T1 (en) 2001-04-12 2002-04-12 New process for the preparation of oxabispidines
US10/474,593 US7169921B2 (en) 2001-04-12 2002-04-12 Process for the preparation of oxabispidines
MXPA03009211A MXPA03009211A (es) 2001-04-12 2002-04-12 METODO PARA LA PREPARACIoN DE OXABISPIDINAS.
AU2002249748A AU2002249748B2 (en) 2001-04-12 2002-04-12 New process for the preparation of oxabispidines
PCT/SE2002/000727 WO2002083690A1 (en) 2001-04-12 2002-04-12 New process for the preparation of oxabispidines
JP2002581445A JP4248880B2 (ja) 2001-04-12 2002-04-12 オキサビスピジンの新製造法
IL15824902A IL158249A0 (en) 2001-04-12 2002-04-12 New process for the preparation of oxabispodines
KR1020037013158A KR100848613B1 (ko) 2001-04-12 2002-04-12 옥사비스피딘의 신규 제조 방법
NZ528515A NZ528515A (en) 2001-04-12 2002-04-12 New process for the preparation of oxabispidines
BR0208861-4A BR0208861A (pt) 2001-04-12 2002-04-12 Processo para a preparação de um composto, e, composto
HK04103893.8A HK1060886B (en) 2001-04-12 2002-04-12 New process for the preparation of oxabispidines
AT02718766T ATE284405T1 (de) 2001-04-12 2002-04-12 Neues verfahren zur herstellung von oxabispidinen
PT02718766T PT1385850E (pt) 2001-04-12 2002-04-12 Novo processo para a preparacao de oxabispidinas
CNB028115759A CN1267435C (zh) 2001-04-12 2002-04-12 制备氧杂双哌啶的新方法
EP02718766A EP1385850B1 (de) 2001-04-12 2002-04-12 Neues verfahren zur herstellung von oxabispidinen
ES02718766T ES2233809T3 (es) 2001-04-12 2002-04-12 Nuevo procedimiento para la preparacion de oxabispidinas.
CA002443475A CA2443475A1 (en) 2001-04-12 2002-04-12 New process for the preparation of oxabispidines
DE60202203T DE60202203T2 (de) 2001-04-12 2002-04-12 Neues verfahren zur herstellung von oxabispidinen
ZA200307676A ZA200307676B (en) 2001-04-12 2003-10-01 New process for the preparation of oxabispidines.
IL158249A IL158249A (en) 2001-04-12 2003-10-02 Process for the preparation of oxabispidines
NO20034526A NO20034526L (no) 2001-04-12 2003-10-09 Nye fremgangsmater for fremstilling av oksabispiner
US11/612,826 US20070197519A1 (en) 2001-04-12 2006-12-19 New Process For The Preparation Of Oxabispidines

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0101324A SE0101324D0 (sv) 2001-04-12 2001-04-12 New process

Publications (1)

Publication Number Publication Date
SE0101324D0 true SE0101324D0 (sv) 2001-04-12

Family

ID=20283781

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0101324A SE0101324D0 (sv) 2001-04-12 2001-04-12 New process

Country Status (19)

Country Link
US (2) US7169921B2 (de)
EP (1) EP1385850B1 (de)
JP (1) JP4248880B2 (de)
KR (1) KR100848613B1 (de)
CN (1) CN1267435C (de)
AT (1) ATE284405T1 (de)
AU (1) AU2002249748B2 (de)
BR (1) BR0208861A (de)
CA (1) CA2443475A1 (de)
DE (1) DE60202203T2 (de)
ES (1) ES2233809T3 (de)
IL (2) IL158249A0 (de)
MX (1) MXPA03009211A (de)
NO (1) NO20034526L (de)
NZ (1) NZ528515A (de)
PT (1) PT1385850E (de)
SE (1) SE0101324D0 (de)
WO (1) WO2002083690A1 (de)
ZA (1) ZA200307676B (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE0101324D0 (sv) * 2001-04-12 2001-04-12 Astrazeneca Ab New process
GB0223712D0 (en) 2002-10-14 2002-11-20 Astrazeneca Ab Chemical intermediate
US20040192738A1 (en) * 2003-03-18 2004-09-30 Aventis Pharma Deutschland Gmbh 2-(Butyl-1-sulfonylamino)-N-[1(R)-(6-methoxypyridin-3-yl)propyl] benzamide, its use as a medicament, and pharmaceutical preparations comprising it
SE0401540D0 (sv) * 2004-06-15 2004-06-15 Astrazeneca Ab New compounds
SE0401539D0 (sv) 2004-06-15 2004-06-15 Astrazeneca Ab New compounds
JP2008543750A (ja) * 2005-06-13 2008-12-04 アストラゼネカ アクチボラグ 心不整脈の処置用の新規オキサビスピジン化合物
CN101198600A (zh) * 2005-06-16 2008-06-11 集润德斯股份公司 氢醌衍生物的合成
US20100222335A1 (en) * 2005-06-20 2010-09-02 Astrazeneca Ab Process For The Preparation Of N,N'-Disubstituted Oxabispidines
WO2006137772A1 (en) * 2005-06-20 2006-12-28 Astrazeneca Ab New physical form of n,n´- disubstituted oxabispidines
MX2007016093A (es) * 2005-06-20 2008-03-10 Astrazeneca Ab Proceso para la produccion de sulfonatos de (alcoxicarbonilamino)- alquilo.
CA2610093A1 (en) * 2005-06-20 2006-12-28 Astrazeneca Ab Process for the preparation of sulfonic acid salts of oxabispidines
WO2006137773A1 (en) * 2005-06-20 2006-12-28 Astrazeneca Ab Process for the isolation of 4-(oxiranylmethoxy)-benzonitriles
AR054391A1 (es) * 2005-06-20 2007-06-20 Astrazeneca Ab Procedimiento para la preparacion de 3,7- dihidroxi-1,5-diazaciclooctanos
SG10201802911RA (en) 2013-03-15 2018-05-30 Global Blood Therapeutics Inc Compounds and uses thereof for the modulation of hemoglobin
EA202092627A1 (ru) 2013-11-18 2021-09-30 Глобал Блад Терапьютикс, Инк. Соединения и их применения для модуляции гемоглобина

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3196154A (en) 1962-05-17 1965-07-20 Sterling Drug Inc 3-substituted-9-methyl-3, 9-diazabicyclo [3.3.1] nonanes
US5110933A (en) * 1989-11-13 1992-05-05 Board Of Regents Of Oklahoma State University Salts of 3-azabicyclo[3.3.1]nonanes as antiarrhythmic agents, and precursors thereof
SE9704709D0 (sv) * 1997-12-17 1997-12-17 Astra Ab Pharmaceutically active compounds
SE9903759D0 (sv) * 1999-10-18 1999-10-18 Astra Ab Pharmaceutically active compounds
SE0101324D0 (sv) * 2001-04-12 2001-04-12 Astrazeneca Ab New process

Also Published As

Publication number Publication date
US7169921B2 (en) 2007-01-30
MXPA03009211A (es) 2004-01-29
ATE284405T1 (de) 2004-12-15
IL158249A0 (en) 2004-05-12
KR100848613B1 (ko) 2008-07-28
KR20030087065A (ko) 2003-11-12
PT1385850E (pt) 2005-03-31
WO2002083690A1 (en) 2002-10-24
HK1060886A1 (en) 2004-08-27
JP4248880B2 (ja) 2009-04-02
DE60202203T2 (de) 2005-12-15
US20040181060A1 (en) 2004-09-16
AU2002249748B2 (en) 2008-02-28
CA2443475A1 (en) 2002-10-24
DE60202203D1 (de) 2005-01-13
NO20034526D0 (no) 2003-10-09
EP1385850B1 (de) 2004-12-08
NO20034526L (no) 2003-10-31
ZA200307676B (en) 2004-07-13
BR0208861A (pt) 2004-10-19
IL158249A (en) 2009-09-01
ES2233809T3 (es) 2005-06-16
US20070197519A1 (en) 2007-08-23
NZ528515A (en) 2005-06-24
JP2004533432A (ja) 2004-11-04
CN1520417A (zh) 2004-08-11
CN1267435C (zh) 2006-08-02
EP1385850A1 (de) 2004-02-04

Similar Documents

Publication Publication Date Title
SE0101324D0 (sv) New process
EP1206937A4 (de) Nikroimidazolpräparationen zur äusseren anwendung zur behandlung der dermatose
MXPA02011370A (es) Iminoazinas substituidas.
BG106622A (en) Process for preparing 4-trifluoromethylsulphinylpyrazole derivative
UA87622C2 (uk) Селективний гербіцидний засіб та проміжні сполуки для одержання 2,4-дигалоген-6-(c2-с3-алкіл)фенілзаміщених похідних тетрамової кислоти
ATE308529T1 (de) Arylsulfonamide als antivirale mittel
IL159931A0 (en) Process for producing pyridine compound
ATE394379T1 (de) 4-alkoxy-cyclohexan-1-amino-carbonsäureester und verfahren zu ihrer herstellung
NZ504084A (en) Processes for producing 7-isoindolinequinolonecarboxylic derivatives and its intermediates, as well as salts of 7-isoindolinequinolonecarboxylic acid derivatives, its hydrates and composition comprising the same as active ingredient
TR200302288T2 (tr) Terapi için yeni bileşikler ve metotlar.
ATE345787T1 (de) Verwendung von cyclohexenon derivaten zur herstellung eines medikaments für die behandlung von dysurie
BR0009453B1 (pt) processo para a preparação de um composto.
BR0214956A (pt) Processo para a preparação de derivados da [1,4,5]-oxadiazepina
ECSP034920A (es) Proceso para la preparacion de derivados de ciclohexanol
FI956230A0 (fi) beta-aminovinyyliketonit, valmistusmenetelmä sekä niiden käyttö beta-diketonien valmistukseen
PT1230211E (pt) Processo para a preparacao de cetiminas
ID27440A (id) Proses untuk menyiapkan penengah-penengah
SE0101323D0 (sv) New process
HU9603178D0 (en) Process for producing benzyl-ethers with phase transformation
EP1391455A4 (de) Verfahren zur herstellung eines chinolincarbaldehyds
HRP20090187T1 (en) Bengamide derivatives and use thereof for the treatment of cancer
BR0112849A (pt) Processo para a preparação de um composto quiral, e, composto quiral
PT1296983E (pt) Novo processo para a preparacao de pirazolopirimidinonas
TH61587A (de)
BRPI0415716A (pt) derivados do ácido acremÈnico